Resistance Training Plus EAAs Has the Best Case for Muscle

Exercise gives amino acids somewhere to go

For preserving muscle with age, the most useful formula is still pleasantly unglamorous: resistance training plus enough high-quality protein or essential amino acids. A 12-week randomized trial in older women adds a molecular detail to that advice. The combination, but neither component alone, increased muscle mass and shifted the follistatin/myostatin ratio in a direction consistent with more anabolic and less catabolic muscle signaling.

That ratio is interesting, not diagnostic. Follistatin can inhibit myostatin-related signaling, while myostatin helps restrain muscle growth. A higher follistatin/myostatin ratio therefore makes biological sense as a marker of a more favorable muscle-building environment. It has not yet earned a role as a clinical test, and it does not prove that changing the ratio caused the observed muscle gain.

The practical conclusion needs less drama than the biomarker: train your muscles regularly, then use nutrition to support the training. By contrast, claims about meal frequency and breakfast deserve much more caution. The available evidence links irregular eating patterns with lower muscle indices; it does not show that eating more often prevents sarcopenia.

What the randomized trial actually found

In a 2026 randomized controlled trial by Jeong et al., 96 healthy women aged 65 and older, all without insulin resistance, were assigned to one of four groups for 12 weeks: no intervention, resistance exercise alone, essential amino acids (EAAs) alone, or both. The exercise groups completed a moderate-intensity, circuit-based 60-minute session three times weekly. The EAA groups took 5.5 grams twice daily, for 11 grams per day.

The combined resistance exercise plus EAA group was the only group with a statistically significant gain in muscle mass. The group effect was F(3,72)=5.042, p<0.001, with partial η²=0.174. That is a moderate-to-large statistical effect in this trial, but the publication details supplied here do not provide an absolute change in muscle mass, so readers cannot translate it into kilograms or judge its clinical size directly.

The same combined group was also the only one to show the reported meaningful shift in the follistatin/myostatin ratio: F(3,72)=5.556, p=0.002, partial η²=0.188. Follistatin increased (p<0.001) and myostatin decreased (p<0.05). The ratio differed significantly from the EAA-only group (p<0.05) and control group (p<0.001). EAA supplementation alone did not produce significant muscle-mass gains or significant improvement on the trial's primary endpoints.

That built-in comparison matters. The study did not test whether amino acids are useless; it tested whether this EAA intervention worked by itself in these women over 12 weeks. It did not. The result fits the idea of anabolic resistance: aging muscle may respond less readily to amino acids unless mechanical loading creates a stronger anabolic stimulus.

Inflammation may be part of the response, but it is not the whole story

Only the combined group significantly reduced all three inflammatory cytokines measured: IL-6, IL-1β, and TNF-α (each p<0.05). Resistance training alone reduced IL-6 and IL-1β, but not all three markers, and it did not significantly increase muscle mass in this trial. These are blood biomarkers, not direct measurements of muscle protein synthesis, so they support a plausible pathway rather than settle the mechanism.

The direction of the cytokine findings matches a 2023 systematic review and meta-analysis by Khalafi et al., which found that resistance training reduces systemic inflammatory markers in older adults with and without chronic disease. That broader result strengthens the case for resistance training as part of sarcopenia care. It does not establish that lower cytokines explain every improvement in muscle mass or function.

The broader evidence favors the combination

The Jeong trial is small, short, and specific to healthy older women, but its main pattern is not an orphan result. A 2026 systematic review and meta-analysis by Xie et al. supports resistance training two to three times per week at 60% to 80% of one-repetition maximum, with two to three sets of 8 to 12 repetitions for major muscle groups, as an evidence-based minimum exercise dose for sarcopenia. Jeong's three-session weekly protocol falls within that range.

Two network meta-analyses also place combined approaches ahead of single-modality approaches. Liao et al.'s 2024 analysis found that protein supplementation plus resistance training outperformed either strategy alone for muscle mass and sarcopenia-related indices across community-dwelling, hospitalized, and institutionalized older adults. Negm et al.'s 2022 network meta-analysis similarly ranked combined exercise and nutrition interventions above unimodal approaches for sarcopenia management.

Those findings support an exercise-first strategy, but they should not be read as a universal EAA prescription. Amino-acid studies differ in participant health, calorie balance, training, dose, and formulation. A 2025 meta-analysis by Huang et al. found heterogeneous and sometimes contradictory results for leucine supplementation in older adults with sarcopenia. In Jeong's trial, the leucine content of the 5.5-gram EAA dose was not reported. That omission prevents a useful comparison with the often discussed 2.5-to-3-gram per-meal leucine target.

Population also changes the answer. A 2025 trial by Muollo et al. reported mixed findings when amino acids were added to a hypocaloric diet and resistance training in older adults with dynapenic obesity. Weight loss, metabolic health, and starting muscle status may all alter whether supplementation adds much beyond training. Healthy women without insulin resistance are not interchangeable with people managing obesity, diabetes, frailty, or established sarcopenia.

Meal frequency is a hypothesis, not a treatment

A 2026 Korean cross-sectional study by Lee et al. analyzed 3,292 adults aged 50 and older. In women, skipping breakfast was associated with low skeletal muscle mass index (odds ratio 1.90; 95% confidence interval 1.08 to 3.34). In men, lower weekly meal frequency was associated with low skeletal muscle mass index: the odds ratio was 4.74 (95% CI 2.39 to 9.42) for 13 to 14 meals per week and 1.96 (95% CI 1.22 to 3.14) for 12 or fewer meals per week.

These results are associations from one point in time. They cannot tell whether skipped meals contributed to lower muscle mass, whether declining function and appetite led people to skip meals, or whether total calorie intake, income, illness, or another factor drove both. The reported breakfast-skipping association in men was also imprecise: OR 2.02, 95% CI 1.01 to 4.04. A lower confidence bound of 1.01 leaves little room between the estimate and no association.

Regular meals may help someone meet protein and energy needs, which is sensible. But meal frequency has not shown itself to be an independent therapeutic lever for preventing or treating sarcopenia. Do not let an observational breakfast headline outrank resistance training because breakfast is easier to photograph.

Where confidence should stop

The follistatin/myostatin finding comes from a single trial, in one sex, over 12 weeks. The study was retrospectively registered after completion, which makes it harder to rule out outcome-selection or protocol changes after the fact. Its analysis denominator of 72 also indicates that not all 96 enrolled participants contributed to the reported F tests. These features reduce the confirmatory weight of the biomarker result.

There is no long-term follow-up showing that the muscle-mass or cytokine changes persist after the program ends. The ratio itself has not been independently validated as a surrogate that predicts strength, falls, disability, or other outcomes that matter in daily life. And controlled programs can look better than self-managed ones. A 2026 feasibility trial by Amini et al. found recruitment, dropout, and adherence problems when community-dwelling older adults attempted a multicomponent exercise, protein, and omega-3 program outside a tightly supervised setting.

For older adults who can safely train, the evidence-backed priority is resistance exercise two to three times weekly, with adequate protein or EAAs used as support rather than a substitute. The molecular ratio is a promising research signal. The barbell, band, or machine remains the intervention with the clearer job description.

Anyone with frailty, severe joint disease, cardiovascular symptoms, kidney disease, or a diagnosed muscle-wasting condition should tailor exercise and supplementation with a clinician or qualified rehabilitation professional. The evidence supports a structured combination; it does not justify treating an EAA tub as a gym membership in powder form.